Caricamento...
Treatment of inflammatory myopathy: emerging therapies and therapeutic targets
Despite the lack of placebo-controlled trials, glucocorticoids are considered the mainstay of initial treatment for idiopathic inflammatory myopathy and myositis-associated interstitial lung disease. Glucocorticoid-sparing agents are often given concomitantly with other immunosuppressive agents, par...
Salvato in:
| Pubblicato in: | Expert Rev Clin Immunol |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4864492/ https://ncbi.nlm.nih.gov/pubmed/26313852 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/1744666X.2015.1082908 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|